84 filings
Page 4 of 5
8-K
h2tvot4aux4
10 Mar 22
Theseus Pharmaceuticals Announces Business Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results
7:15am
8-K
fmmdbvjaupsl c85rrmd
10 Jan 22
Other Events
7:16am
10-Q
lfj9qxl80c5f
15 Nov 21
Quarterly report
7:36am
8-K
i6vy8zg bi9tf
15 Nov 21
Theseus Pharmaceuticals Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results
7:30am
8-K
cqno8ka vdoq49k
27 Oct 21
Other Events
4:14pm
S-8
pma34lrh
8 Oct 21
Registration of securities for employees
4:48pm
424B4
158gwutrc9x6tv3
7 Oct 21
Prospectus supplement with pricing info
5:03pm
EFFECT
vc6sm7o
7 Oct 21
Notice of effectiveness
12:15am
S-1MEF
lioiqqpc9 9m
6 Oct 21
Registration of additional securities for an S-1
7:38pm
CERT
p2ktvxc9jhujv
6 Oct 21
Certification of approval for exchange listing
11:58am
SEC STAFF
mll367mebv ol
6 Oct 21
SEC staff action: Order
12:00am
CORRESP
jh6iasy gei8
4 Oct 21
Correspondence with SEC
12:00am
CORRESP
35iuxh1dm40v5au4k
4 Oct 21
Correspondence with SEC
12:00am
8-A12B
lcnm6dp nwshhtfz
1 Oct 21
Registration of securities on exchange
4:19pm
S-1/A
v8jz9qm7kmt0
30 Sep 21
IPO registration (amended)
6:33am
S-1
7yub ash5t
15 Sep 21
IPO registration
4:04pm
SEC STAFF
alp04okr585c7xv9zjqd
30 Aug 21
SEC staff action: Order
12:00am
DRS/A
svt tceu73f
23 Aug 21
Draft registration statement (amended)
12:00am
DRSLTR
guv8e8kmknrkf6ugrze
23 Aug 21
Correspondence regarding draft registration statement
12:00am
UPLOAD
ae9td1ig7xpzo72ev
11 Aug 21
Letter from SEC
12:00am